Ann: ResApp Announces SleepCheck, a Sleep Apnoea Screening App, page-169

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 169 Last

Share
Profile

Follow
w_i_z_z_a

803 Posts.

155

01/04/20

16:00

Post #: 43822554
Share
Originally posted by TerribleTadpole: ↑

I suspect that the muted response from the market is because this is a very watered down version of what we were expecting for sleep apnea. In particular, there is no health service connect: it's purely a self-diagnostic tool. That's useful because it can save people the effort and cost of filling in sleep-quality survey forms, and visiting specialists, and wiring up for the sleep study. But there is the issue around what people will be prepared to pay for their sleep test when there are so many ad-funded alternatives available purporting to do the same thing (even if they don't, how will most people discern that).

This offering also brings some risks with it:
If people don't set it up properly or don't use it well, and get invalid results it may damage the product's credibility.
Putting SleepCheck into the self-check domain prior to assessment by formal health care there is the risk of cutting it out of the diagnostic toolkit used (and paid for) by clinicians because it's "already been done".

From earlier announcements I was expecting a product more closely connected to the provision of formal health care by qualified clinicians.

Expand

That is a valid explanation on why sp failed to be significantly affected.
my gut feel is the sp didn't respond because:
1. People are dumb and don't get it, and
2. There was no mention of collaboration with a big listed company like resmed or philips.

Looking forward to 1 of the above points being rectified.
RAP Price at posting: 19.5¢ Sentiment: Buy Disclosure: Held
26 Upvote

0 Great analysis

Reply

Top Stories

CU6

Clarity progresses SECuRE trial with positive safety results

GTR

GTI extends uranium mineralisation at Lo Hema through development drilling

DXB

Dimerix begins recruiting young kidney disease patients in Mexico for Phase 3

3 stocks with antimony news on Thursday

SS1

Sun Silver confirms high-grade extension theory at Maverick Springs with 79.6 g/t intercept